New Hope for DVT Patients

Deep Vein Thrombosis – DVT, is a serious condition, yet some treatments can cause a serious risk of bleeding.  However, there is hope for a different approach according to a new study.

The Centres for Disease Control and Prevention (CDC) report that more than nine hundred thousand people in the United States live with DVT and PE (Pulmonary Embolism), which to us in everyday language is a clot on the lung.  It is estimated that between sixty and one hundred thousand individuals die from DVT/PE.

The new study was carried out by a team of researchers from the Institute of cardiovascular science at Birmingham University in the United Kingdom, led by Dr. Alexander Brill, finding an alternative to anticoagulants. As part of the research, scientists looked at mast cells to see if they are partly responsible for DVT.  When they managed to ‘silence’ the gene forming them, the mice used in the experiment were protected from DVT.

It would appear the reason most anti-clotting medication cause bleeding, is that it affects the body’s natural response to a cut. Our body’s blood coagulation system is a helpful form of clotting to prevent continual bleeding, however, anti-clotting medication affects this process.

Mast cell inhibitors are already being used for illnesses such as asthma and hay fever and with further trials, it is hoped that a new drug may lead to the prevention from DVT.  As they are already licensed and in use, they could be quickly tested and made available to the public.  Dr. Brill says this is particularly exciting for DVT patients.  Personally, I hope this will be exciting for stroke survivors too.

Leave a Reply

Your email address will not be published. Required fields are marked *